BeOne Medicines Ltd.
BeOne Medicines Ltd.（ONC）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
onc · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$436
Consensus
$399
+47.3% upside
Low
$340
Median: $409 · Last Close: $270.97
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$399.11
47.3% upside
High Target
$436
60.9%
Low Target
$340
25.5%
Current Price
$270.97
as of today
Based on analyst price targets, the ONC stock price prediction for the next 12 months ranges from $340 to $436. The consensus ONC price forecast of $399.11 implies 47.3% upside from the current price of $270.97.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $258.77 | ↓ 4.50% |
1-day model range: $257.75–$259.78. Peak: $259.78 (-4.50%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $305 | +12.7% |
| 2028 | $330 | +21.9% |
| 2029 | $348 | +28.4% |
| 2030 | $360 | +32.9% |
| 2031 | — | +35.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ONC · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-15 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-05-07 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-07 | Barclays | Maintains | Overweight→Overweight |
| 2026-05-07 | Truist Securities | Maintains | Buy→Buy |
| 2026-03-16 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2026-02-27 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-02-27 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-27 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on BeOne Medicines Ltd. (ONC) stock. Of the recent 38 rating actions, 0 were upgrades and 1 were downgrades. 14 analysts currently cover ONC.
分析师推荐趋势
ONC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$6.5B
↓ 23.5% YoY
Revenue Next Year
$7.5B
↑ 15.4% YoY
EPS This Year
$6.73
EPS Next Year
$9.79
↑ 45.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast ONC EPS of $6.73 for the current fiscal year, based on estimates from 12 analysts. The ONC revenue forecast is $6.5B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ONC 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ONC 的共识目标价为 $399.11（+47.3% 上行空间），分析师共识为 Buy。
ONC 的短期预测（明日）为 $258.77（-4.50%）。 ONC 对 2027 年的股价预测均值为 $305。 ONC 对 2030 年的预测区间为 $345–$376。
BeOne Medicines Ltd. 在 NASDAQ 上市，代码 ONC。ONC 在 2027 年的整体展望偏积极，在覆盖分析师中约 93% 对应 Buy 共识。
常见问题
ONC 预测 · 8 个问题根据 14 位华尔街分析师，ONC 的 12 个月平均目标价为 $399.11，最高 $436.00、最低 $340.00。若有图表，中位目标价可在上方查看。相对当前价 $270.97，隐含约 +47.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.